Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Pharma awaits FDA Guidance to Navigate the Murky Waters of Ads Via the Internet and Social Media

Vanessa Caceres  |  Issue: November 2010  |  November 1, 2010

Internet advertising now and in the future will also affect physicians because patients will ask questions about what they see online, as they do now with other DTC advertising, Dr. Cush says. “A person who has fibromyalgia may want to know about Humira. They may want to spend four or five minutes of their 15-minute visit discussing the drug because their cousin sent them a Facebook feed for it,” he says.

The guidance from the FDA could also have an ancillary effect on physicians as they start promoting their practice and experience via the Internet, Dr. Cush adds.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

He believes the guidance from the FDA regarding Internet advertising will address what could specifically violate FDA regulations. Dr. Buckley believes the guidance will be very similar to that for print media, requiring pharmaceutical companies to have their online ads approved by the FDA before circulation, list risks as well as benefits, and not make unjustified claims about superiority.

Vanessa Caceres is a medical writer and editor in Florida.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Page: 1 2 3 | Single Page
Share: 

Filed under:EthicsProfessional TopicsTechnology Tagged with:FDAIndustryInternetPrescription drugsSafetySocial MediaTechnology

Related Articles

    Drug Commercials—How Are They Still a Thing?

    July 19, 2018

    Picture this: It’s 3 o’clock in the morning. You can’t sleep. You settle in front of the television to watch a rerun of Dirty Dancing. And then it hits you: Ask your doctor. Even as your eyelids sag, some part of your primitive forebrain snaps to attention. Medical training has turned us all into multitaskers,…

    Rohane Hamilton / shutterstock.com

    Healthcare Accessibility for People with Rheumatic Disease in New Haven, CT

    October 13, 2021

    The COVID-19 pandemic exacerbated wide disparities that exist in the U.S. healthcare system. During the pandemic, the clinical practice in the Section of Rheumatology, Allergy & Immunology at Yale School of Medicine (YSM), New Haven, Conn., rapidly pivoted from face-to-face visits to telehealth to keep our patients and providers safe. Many patients quickly adapted and…

    Navigating the Social Media Highway

    January 17, 2011

    Rheumatologists spot speed bumps, opportunities

    How A Social Media Policy Can Protect Your Practice

    February 3, 2012

    While social media can be a beneficial marketing tool, it is important for rheumatologists to address the proper ways to use this outreach both inside and outside the workplace through a specific media policy

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences